Heparin Pharmacokinetics in Response to Temperature Variation during Cardiopulmonary Bypass
Not Applicable
- Conditions
- Anticoagulant useSurgery requiring cardiopulmonary bypassTherapeutic intra-operative hypothermiaSurgery - Other surgeryBlood - Clotting disordersCardiovascular - Other cardiovascular diseasesAnaesthesiology - Other anaesthesiology
- Registration Number
- ACTRN12621001270808
- Lead Sponsor
- Department of Anaesthesia, Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patient undergoing cardiac surgery requiring cardiopulmonary bypass
Exclusion Criteria
Administration of therapeutic low molecular weight heparin or unfractionated heparin infusion < 24 hours prior to planned cardiac surgery
End-stage renal failure or anticipated requirement for haemofiltration on cardiopulmonary bypass
Anticipated duration of cardiopulmonary bypass < 60 minutes
Plan for intra-operative cooling below 25°C
BMI > 30 kg/m²
Patients unable to give informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method